Metraipolis › archive › dc_6809c5cead47
Clinical predictors of tocilizumab response in moderate-to-severe thyroid eye disease: a large single-center retrospective cohort study — Europe PMC PMID:42125230
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42125230
- DOI
- 10.3389/fendo.2026.1823718
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T04:12:28.003Z
- SHA-256 of the archived text
16a88dfb2150a8990f8ff63227dc6df92706bd7f024be6a03f56aacc61001f4e- Stable URL of this page
https://metraipolis.com/documento/dc_6809c5cead47
How to cite
Clinical predictors of tocilizumab response in moderate-to-severe thyroid eye disease: a large single-center retrospective cohort study — Europe PMC PMID:42125230 — Europe PMC (en), https://europepmc.org/article/MED/42125230 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6809c5cead47 (Metraipolis archive dc_6809c5cead47, sha256 16a88dfb2150a8990f8ff63227dc6df92706bd7f024be6a03f56aacc61001f4e)
BibTeX
@misc{dc6809c5cead47,
title = {Clinical predictors of tocilizumab response in moderate-to-severe thyroid eye disease: a large single-center retrospective cohort study — Europe PMC PMID:42125230},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42125230},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6809c5cead47; sha256 16a88dfb2150a8990f8ff63227dc6df92706bd7f024be6a03f56aacc61001f4e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42125230. Agents can read the archived copy with the MCP tool read_document.